Skip to main content
OpenTrials

Clinical trial condition

Leptomeningeal Metastasis

Explore clinical trials studying Leptomeningeal Metastasis. Study availability and eligibility vary by location and protocol.

47 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Leptomeningeal Metastasis trial results

Not yet recruiting

AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center Study

NCT07005791

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Jiangning Hospital Affiliated to Nanjing Medical University Nanjing, Jiangsu, China
  • Nanjing Drum-tower Hospital Affiliated to Medical College of Nanjing University Nanjing, Jiangsu, China
View Trial Details
Active, not recruiting

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

NCT06462222

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Cancer Center, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, China
View Trial Details
Active, not recruiting

Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis

NCT06809530

Conditions
CTLA4, Central Nervous System Neoplasms, Leptomeningeal Metastasis, +9 more
Locations
  • Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, Beijing Municipality, China
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
View Trial Details
Active, not recruiting

Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis

NCT06762080

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Jinshan Hospital, Fudan University Shanghai, China
View Trial Details

Related conditions